Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: A 6-year survey and cost-effectiveness analysis

Digestive and Liver Disease

Volumn 38, Issue 8, 2006, Pages 588-595

  Testoni, P A ^a   Mariani, A ^a   Masci, E ^a   Curioni, S ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

ERCP; Gabexate prophylaxis; Post procedural pancreatitis

Indexed keywords

GABEXATE MESILATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG DOSE REGIMEN; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HOSPITAL COST; HUMAN; HYPERAMYLASEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLASES; CHILD; CHILD, PRESCHOOL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COST-BENEFIT ANALYSIS; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; GABEXATE; HUMANS; HYPERAMYLASEMIA; INCIDENCE; ITALY; MALE; MIDDLE AGED; PANCREATITIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SERINE PROTEINASE INHIBITORS; TREATMENT OUTCOME;

EID: 33748504990     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.04.001     Document Type: Article

References (31)

1. Rabenstein T., Roggenbuck S., Framke B., Martus P., Fisher B., and Nusko G. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?. Gastrointest Endosc 55 (2002) 476-483
2. Moretò M., Zaballa M., Casado I., Merino O., Rueda M., and Ramirez K. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57 (2003) 1-7
3. Murray B., Carter R., Imrie C., Evans S., and O'Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 124 (2003) 1786-1791
4. Poon R.T.P., Yeung C., Liu C.L., Lam C.L., Yuen W.K., and Lo C.M. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomized controlled trial. Gut 52 (2003) 1768-1773
5. Masci E., Cavallini G., Mariani A., Frullini L., Testoni P.A., and Curioni S. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol 98 (2003) 2182-2186
6. Andriulli A., Leandro G., Niro G., Mangia A., Festa V., and Gambassi G. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51 (2000) 1-7
7. Tamura Y., Hirado M., and Okamura K. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, and C1 esterase. Biochim Biophys Acta 484 (1977) 417-422
8. Cavallini G., Tittobello A., Frulloni L., Masci E., Mariani A., and Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 335 (1996) 919-923
9. Pasha T.M., Therneau T., and Petersen B.T. Economic analysis of gabexate mesilate in post-ERCP pancreatitis. Gastroenterology 112 (1997) A471 [abstract]
10. Andriulli A., Clemente R., Solmi L., Terrazzi V., Suriani R., and Sigillito R. Gabexate or somatostatin administration before ERCP in patients at higth risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
11. Testoni P.A., and Bagnolo F. Twenty-four-hour pain associated with hyperamylasemia higher than five times the upper normal limit is the most reliable indicator of post-ERCP pancreatitis. Gastrointest Endosc 53 (2001) 33-39
12. Cotton P.B., Lehman G.A., Vennes J., Geenen J.E., Russell L.C., and Meyers W.C. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37 (1991) 383-393
13. Bradley E.L. A clinically-based classification system for acute pancreatitis. Arch Surg 128 (1993) 586-590
14. Sherman S., Troiano F.P., Hawes R.H., O'Connor K.W., and Lehman G.A. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol 86 (1991) 586-590
15. Freeman M.L., Nelson D.B., Sherman S., Haber G.B., Herman M.E., and Dorsher P.J. Complications of endoscopic biliary sphincterotomy. N Engl J Med 335 (1996) 909-918
16. Loperfido S., Angelini G., Benedetti G., Chilovi F., Costan F., and De Berardinis F. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48 (1998) 1-10
17. Masci E., Toti G., Mariani A., Curioni S., Lomazzi A., and Dinelli M. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96 (2001) 417-423
18. Freeman M.L., DiSario J.A., Nelson D.B., Fennerty M.B., Lee J.B., and Bjorkman D.J. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54 (2001) 425-434
19. Vandervoort J., Soetikno R.M., Tham T.C.K., Wong R.C., Ferrari A.P., and Montes H. Risk factors for complications after performance of ERCP. Gastrointest Endosc 56 (2002) 652-656
20. Freeman M.L. Post-ERCP pancreatitis: patient- and technique-related risk factors. J Pancreas 3 (2002) 169-176
21. Masci E., Mariani A., Curioni S., and Testoni P.A. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 35 (2003) 830-834
22. Ministero della Sanità. Aggiornamento delle tariffe delle prestazioni di assistenza ospedaliera di cui al DM 14.12.1994; DM 30.6.97 SO. GU no. 209: 8.9.1997.
23. Testoni P.A., Bagnolo F., Andriulli A., Bernasconi G., Crotta S., and Lella F. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 15 (2001) 965-972
24. Deviere J., Le Moine O., van Laethem J.L., Eisendrath P., Ghilain A., and Severs N. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120 (2001) 498-505
25. Gottlieb K., and Sherman S. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 8 (1998) 87-114
26. Akashi R., Kiyozumi T., Tanaka T., Sakurai K., Oda Y., and Sagara K. Mechanism of pancreatitis caused by ERCP. Gastrointest Endosc 55 (2002) 50-54
27. Jowell P.S., Baillie J., Branch M.S., Affronti J., Browning C.L., and Bute B.P. Quantitative assessment of procedural competence. A prospective study of training in endoscope retrograde cholangiopancreatography. Ann Intern Med 125 (1996) 983-989
28. Eisen G.M., Dominitz J.A., Faigel D.O., Goldstein J.A., Petersen B.T., and Raddawi H.M. Guidelines for advanced endoscopic training. Gastrointest Endosc 53 (2001) 846-848
29. Hellier M.D., and Morris A.I. ERCP-training-time for change. Gut 47 (2000) 459-460
30. Rabenstein T., Schneider H.T., Niklas M., Ruppert T., Katalinic A., and Hahn E.G. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc 50 (1999) 628-636
31. Rabenstein T., and Hahn E.G. Post-ERCP pancreatitis: is the endoscopist's experience the major risk factor?. J Pancreas 3 (2002) 177-187